2.56
Precedente Chiudi:
$2.451
Aprire:
$2.4392
Volume 24 ore:
26,193
Relative Volume:
0.49
Capitalizzazione di mercato:
$78.44M
Reddito:
$6.21M
Utile/perdita netta:
$-19.92M
Rapporto P/E:
-2.4381
EPS:
-1.05
Flusso di cassa netto:
$-16.76M
1 W Prestazione:
+12.28%
1M Prestazione:
+4.34%
6M Prestazione:
-12.92%
1 anno Prestazione:
+1.19%
InspireMD Inc. Stock (NSPR) Company Profile
Nome
InspireMD Inc.
Settore
Industria
Telefono
972 3 6917691
Indirizzo
4 Menorat Hamaor Street, Tel Aviv
Confronta NSPR con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
NSPR
InspireMD Inc.
|
2.56 | 68.16M | 6.21M | -19.92M | -16.76M | -1.05 |
![]()
ABT
Abbott Laboratories
|
132.85 | 231.49B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
104.50 | 154.81B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
382.35 | 145.13B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
82.41 | 108.21B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.73 | 44.64B | 5.54B | 4.18B | 623.10M | 7.00 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2016-01-07 | Iniziato | Rodman & Renshaw | Buy |
2015-03-13 | Downgrade | Oppenheimer | Outperform → Perform |
2013-11-26 | Iniziato | Oppenheimer | Outperform |
InspireMD Inc. Borsa (NSPR) Ultime notizie
Inspire Medical Systems (NYSE:INSP) and InspireMD (NYSE:NSPR) Head-To-Head Contrast - Defense World
OrthoPediatrics (NASDAQ:KIDS) versus InspireMD (NYSE:NSPR) Critical Review - Defense World
Piper Sandler Lowers InspireMD (NYSE:NSPR) Price Target to $4.00 - Defense World
InspireMD Inc. Reports Q1 2025 Financial Results - MSN
InspireMD outlines Q3 2025 FDA approval target for CGuard Prime - MSN
InspireMD Inc’s Earnings Call: Growth Amid Challenges - MSN
InspireMD (NSPR) Sees Price Target Reduction by Piper Sandler | - GuruFocus
InspireMD price target lowered to $4 from $4.50 at Piper Sandler - TipRanks
Piper Sandler cuts InspireMD stock price target to $4.00 By Investing.com - Investing.com South Africa
Piper Sandler cuts InspireMD stock price target to $4.00 - Investing.com Australia
InspireMD (NSPR) Price Target Reduced, FDA Approval Timeline Adj - GuruFocus
InspireMD initiated with a Buy at Lake Street - TipRanks
InspireMD, Inc. (NASDAQ:NSPR) Q1 2025 Earnings Call Transcript - Insider Monkey
InspireMD Inc (NSPR) Q1 2025 Earnings Report Preview: What To Lo - GuruFocus
InspireMD Inc (NSPR) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Operational Challenges By GuruFocus - Investing.com Canada
Earnings call transcript: InspireMD Q1 2025 shows mixed results - Investing.com
InspireMD earnings beat by $0.09, revenue fell short of estimates - Investing.com Canada
InspireMD reports Q1 EPS (22c) vs (21c) last year - TipRanks
InspireMD (NSPR) Posts Slight Increase in Q1 Revenue | NSPR Stoc - GuruFocus
InspireMD Inc (NSPR) Q1 2025 Earnings: Revenue of $1.53M Beats E - GuruFocus
InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic - NewsBreak: Local News & Alerts
InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic By Stocktwits - Investing.com India
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
InspireMD Reports First Quarter 2025 Financial Results - The Manila Times
InspireMD, Inc. Reports Q1 2025 Financial Results and Anticipates FDA Approval for CGuard™ Prime Carotid Stent System - Nasdaq
Renaissance Technologies LLC Invests $27,000 in InspireMD, Inc. (NYSE:NSPR) - Defense World
INSPIREMD Earnings Results: $NSPR Reports Quarterly Earnings - Nasdaq
INSPIREMD Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More - Nasdaq
InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com - Defense World
InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference - The Manila Times
InspireMD's Revolutionary Stroke Prevention Technology Takes Center Stage at Major Healthcare Conference - Stock Titan
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World
InspireMD to Announce First Quarter 2025 Financial Results - GlobeNewswire
InspireMD, Inc. to Announce First Quarter 2025 Financial Results on May 9, 2025 - Nasdaq
Destination Excellence: New Clinical Partnerships Inspire MD Students, Aid Community Organizations - Drexel
InspireMD Q1 2025 Earnings: Leading Carotid Stent Developer Reveals Financial Performance Date - Stock Titan
StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - Defense World
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - Defense World
InspireMD at 24th Annual Needham: Strategic Moves in Healthcare By Investing.com - Investing.com Canada
InspireMD announces inducement grants under Nasdaq listing rule - TipRanks
Inspiremd Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
InspireMD Expands Team: 299K Shares Granted to New Medical Device Experts - Stock Titan
InspireMD files $200M mixed securities shelf - MSN
InspireMD Inc Files For Mixed Shelf Of Up To $200 MillionSEC Filing - MarketScreener
InspireMD Files $200 Million Mixed Shelf - marketscreener.com
InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - Defense World
InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference - The Manila Times
InspireMD CEO to Reveal Latest CGuard Strategy at Major Healthcare Conference - Stock Titan
InspireMD Inc. Azioni (NSPR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):